Related Experiment Video
Updated: May 17, 2026

08:25
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database
David S Goldberg1, James D Lewis, Scott D Halpern
1Division of Gastroenterology, Department of Medicine, Hospital of the University of Pennsylvania, PA 19104, USA. david.goldberg@uphs.upenn.edu
Pharmacoepidemiology and Drug Safety
|November 6, 2012
Summary
A new algorithm using International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) codes can effectively identify patients with hepatocellular carcinoma (HCC). This method is crucial for future population-based studies on HCC epidemiology and treatment effectiveness.
Area of Science:
- Hepatobiliary Medicine
- Medical Informatics
- Epidemiology
Background:
- International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM)-based algorithms for identifying hepatocellular carcinoma (HCC) are lacking outside specific healthcare systems.
- Developing and validating such algorithms is essential for population-based research on HCC epidemiology, treatment efficacy, and safety.
Purpose of the Study:
- To develop and validate an ICD-9-CM-based algorithm for identifying patients with hepatocellular carcinoma (HCC).
- To enable population-based studies on HCC epidemiology and comparative effectiveness of therapies.
Main Methods:
- Electronic medical records from two tertiary care hospitals were queried.
- The algorithm identified patients with at least two ICD-9-CM codes for chronic liver disease/cirrhosis and two ICD-9-CM codes for HCC.
- Positive predictive value (PPV) was determined by expert medical record review.
Main Results:
- The algorithm identified 101 patients, with 88 confirmed cases of HCC (PPV: 87.1%).
- Sensitivity was 91.7% for confirmed HCC cases, and specificity was 98.7% for non-HCC chronic liver disease patients.
- Excluding patients receiving recent chemotherapy improved the PPV to 91.6%.
Conclusions:
- An algorithm requiring at least two ICD-9-CM codes for chronic liver disease/cirrhosis and two for HCC demonstrates high PPV.
- This claims-based algorithm is suitable for future epidemiologic studies of HCC.
- It can also be used to evaluate outcomes and adverse events of HCC therapies.
